Table 4
Most commonly reported adverse events (AE) (⩾5% of total subjects) in the intention to treat (ITT) population (no. of patients (%))
CRx-102 (n = 42)
Placebo (n = 41)
Total (n = 83)
Subjects with at least one AE
27 (64)
13 (32)
40 (48)
Headache
22 (52)
6 (15)
28 (34)
Nausea
9 (21)
0
9 (11)